About Metabolomic Discoveries
Metabolomic Discoveries is a company based in Potsdam (Germany) founded in 2009 was acquired by Metabolon in September 2017. Metabolomic Discoveries operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Potsdam, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Metabolomic Discoveries
Detailed funding history for Metabolomic Discoveries
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Metabolomic Discoveries
Metabolomic Discoveries has secured backing from 1 investor. Prominent investors backing the company include Metabolon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Solutions for biomarker discovery and diagnostic testing are provided.
|
Locked | Locked | Locked |
Investor details for Metabolomic Discoveries
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Metabolomic Discoveries
Investment portfolio details for Metabolomic Discoveries
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Metabolomic Discoveries
Detailed financials for Metabolomic Discoveries
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metabolomic Discoveries Comparisons
Peer comparison for Metabolomic Discoveries
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Metabolomic Discoveries
Metabolomic Discoveries operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Metabolomic Discoveries
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metabolomic Discoveries
Complete news archive for Metabolomic Discoveries
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metabolomic Discoveries
Metabolomic Discoveries was founded in 2009.
Metabolomic Discoveries is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.
Metabolomic Discoveries was founded in 2009 in Potsdam, Germany, within the biotechnology sector. Research and analytical services are offered, including high-resolution metabolite profiling of biological materials, lipidomics, and related analytics. Data processing involves statistical and multivariate analysis, supported by bioinformatics for integration. The TagFinder software package is available for GC-MS metabolomics data handling, while Kenkodo, a metabolism-based body tracking tool, is provided in beta version.
Metabolomic Discoveries's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Metabolomic Discoveries has 1 investor. Key investors include Metabolon.